Q2 Missed Guidance by 60%, PAT Fell 17% — Order Book Surge Is the Only Win
EMS promised 30-35% revenue growth; delivered 12.4% and saw profit slide 16.8% lower. The ₹3,152 Crore order book is real and visible for 2+ years, but ₹450 Crore in stuck government receivables and near-term execution risk make the case hold, not buy.
30–35% YoY
set on FY27 Q1 call
12.4% YoY
₹193.9 Cr
60% below target
guidance gap
-16.8% YoY
₹23.4 Cr
On the face of the numbers, EMS Limited cleared its top-line bar: Q2 consolidated revenue of ₹193.9 Crore exceeded the ₹160.89 Crore in standalone revenue management cited on the call. But the market's read of that result is not on the absolute, it is on the miss. Management had guided for 30–35% year-on-year revenue growth in Q2 (set during the Q1 earnings call, in the context of a full-year FY27 target of ₹900–950 Crore implying 50% YoY growth). This quarter delivered 12.4% YoY growth — a 60% shortfall against the low end of the range. Worse, consolidated profit fell 16.8% year-on-year to ₹23.4 Crore, directly contradicting management's on-call claim of 50% EBITDA and PAT growth. That 67-percentage-point divergence (claimed +50%, actual −17%) is the core tension of this quarter.
Claims vs. the Reality: The Grading
50% EBITDA and PAT growth in Q2
ContradictedConsolidated PAT −16.8% YoY (₹23.4 Cr). EBITDA margin compressed from 20.2% (Q1) to 18.5% (Q2).
Order book of ₹3,152 Cr; ₹900 Cr added this quarter
SupportedSupported by state-wise breakdown: ₹2,619 Cr CAPEX, ₹533 Cr O&M work. Aligns with CEO commentary on Jal board tender wins.
Receivables issue in Uttarakhand being resolved; fund flow normalizing
Partial₹450+ Cr trade receivables still outstanding; payment delays 6+ months. Government portal corrected recently, but inflow not yet visible.
Can execute 40% of order book per year at typical 2–2.5 year project cycles
OverstatedIf valid: ₹3,152 Cr ÷ 2.5 years = ₹1,261 Cr annual capacity. Q2 delivered ₹193.9 Cr (15% of claimed capacity). Execution risk remains unproven.
The dividend of this table: management's near-term credibility has taken a hit. Promised 30–35% growth, delivered 12.4%. Claimed 50% profit expansion, saw profit contract 17%. The order book and receivables narratives are intact, but they are forward-looking; Q2 itself was a miss, and the miss was real.
The Offset: ₹3,152 Crore Order Book
What prevents this quarter from being a simple downgrade is the order book. EMS added ₹900 Crore in new CAPEX and O&M work in Q2 alone, pushing the total visible order book to ₹3,152 Crore — equivalent to 1.5× the company's trailing annual revenue. For a civil engineering firm operating in water supply and sewage treatment (the bedrock of India's 15-lakh-crore water infrastructure opportunity), that visibility is material. The order book is real, granular by state and project type, and anchored to tender wins from Delhi Jal Board, PHED Rajasthan, UP Jal Nigam, and Central government Namami Ganga and Amrit projects. But the order book's size is not the same as the order book's execution. Management's assumption that 40% of the outstanding order book can convert to revenue annually — yielding ₹1,261 Crore per year at the current ₹3,152 Crore stock — is an aspiration, not a track record. Q2 delivered ₹193.9 Crore against a ₹3,152 Crore order book, implying only a 6.2% conversion rate on the quarter. If the 40% annual assumption were real, the company would be tracking to ₹1,261 Crore annualized from that order book alone; clearly, it is not. Project lead times (2–2.5 years typical), government approval delays, and site conditions will determine the real run rate.
The ₹450 Crore Receivables Drag
Underlying Q2's miss is a working-capital crunch management has aired openly: ₹450+ Crore in trade receivables, primarily from government clients in Uttarakhand. These are not disputed — they are due from state governments under water supply and sewage schemes — but they are old. Payment delays have stretched from the typical 2–3 months to 6+ months, citing government payment portal changes (a central policy shift to co-funding models between union and state authorities). The portal was corrected recently, but money has not yet flowed. This receivables drag is not unique to EMS (Indian infrastructure projects routinely face government payment delays), but it is material to this quarter. With ₹450+ Crore stuck in receivables and only ₹193.9 Crore in quarterly revenue, the working-capital cycle is impaired. Profit fell partly because revenue growth slowed, partly because the company is burning cash on non-funded execution. Management expects the payment flow to accelerate in Q3–Q4 FY27, but that is a forecast, not a fait accompli. For a holder, it means near-term cash conversion remains a watch.
What Changed on This Call
Q3–Q4 guidance revised down: from >50% QoQ growth (prior call) to 30–35% QoQ (this call)
Order book upgraded to ₹3,152 Cr total (₹900 Cr added in one quarter)
FY27 target maintained at ₹900–950 Cr (not raised despite order book upgrade)
Receivables forecast: normalization by Q4 FY27 (from government portal reset); timing uncertain
EBITDA margin target held at 25%+ by year-end (vs current 18.5%); PAT margin 25% also restated
The Bull–Bear Ledger
Order book of ₹3,152 Cr provides 2+ years of project visibility at typical execution rates
Sector tailwind: 15-lakh-crore water/sewage opportunity; EMS is ~1% of that market
20-year track record executing government water and sewage projects
Q2 guidance missed by 60%; credibility dented going forward
PAT fell 16.8% YoY despite revenue growth; margin compression, not recovery
₹450+ Cr government receivables stuck 6+ months; material working-capital drag
EBITDA margin target of 25% requires 6.5pp expansion in one half-year; execution risk high
Standalone vs. consolidated divergence (CEO cited ₹160.89 Cr standalone vs ₹193.9 Cr consolidated)
Risks, Ranked by Concern
Government receivables remain stuck into Q3 or later
High₹450+ Cr represents 2.3× Q2 revenue. If collections slip beyond Q4, the company faces a working-capital crisis and potential covenant pressure on any debt.
Q3–Q4 growth misses 30–35% QoQ guidance (again)
HighA second miss would signal execution issues beyond transient receivables delays. Stock would likely re-rate lower, and the order book thesis would be questioned.
EBITDA margin stays below 20% through Q4 (misses 25% target)
MediumMargin compression amid cost inflation would imply the operating leverage narrative is unproven. Profitability recovery would be delayed into FY28.
Order book concentration: 35% in UP, 27% in Rajasthan
MediumIf either state faces budget cuts or payment authority changes, project delays and receivables aging could accelerate.
Project execution delays from monsoon, weather, or government approvals
MediumQ2 saw Uttarakhand monsoon-delayed work. Similar delays in Q3–Q4 would roll revenue forward and push receivables further out.
How the Street Is Positioned
EMS trades at ₹303.85 as of 16 November 2026, down 70.1% from its all-time high of ₹1,016 and trading 18.7% above its 52-week low of ₹256.05. The stock is below its 50-day and 200-day moving averages (SMA50 ₹331.45, SMA200 ₹344.97), signaling a bearish trend. RSI sits at 43.8 (neutral), and volume remains normal — no panic selling, no fresh accumulation. Ownership is thin and illiquid: FII ownership stands at just 0.44%, DII at 0.02%, leaving the promoter (69.70%) in full control. This is an unloved stock in institutional portfolios. Recent bulk/block deals (Sep 2026) show trading activity in the ₹395–₹400 range, with no promoter-linked insider selling near the highs — a neutral signal. The market's verdict, read through price action, is clear: wait and see. The stock has repriced from ₹504 (52-week high) to ₹303.85 on the back of the Q2 miss and guidance cut. That repricing is not irrational — a 60% revenue guidance miss and 17% profit decline warrant a reset. But with volume normal and no distressed selling, the market is not panicking; it is simply deferring to Q3 for proof. If the company executes 30–35% QoQ growth in the next quarter, re-rating will follow.
What to Watch Next
1 · Q3 FY27 QoQ revenue growth (due ~Nov/Dec 2026)
Management guided 30–35% QoQ from Q2 (vs Q1). If Q3 hits ₹252–266 Cr, the company is back on track and Q2 was a stumble. If it misses again, execution is the issue, not receivables. This single data point will reset expectations for FY27 and beyond.
2 · Government receivables clearance (Uttarakhand, UP, others)
The ₹450+ Cr outstanding must start flowing in Q3–Q4. Watch quarterly cash flow statements and trade receivables aging. If receivables stabilize below ₹400 Cr by year-end and working capital cycle improves, the liquidity narrative shifts. If they remain above ₹450 Cr, the working capital burden persists.
3 · EBITDA margin progression (Q3 and Q4 target 25%)
Current EBITDA margin is 18.5%; management targets 25% by FY27 end. Watch Q3 margin. If it moves toward 21–22%, the recovery is real. If it stays flat or compresses further, cost inflation or pricing pressure is too high, and the margin story is broken.
EMS Limited is a structurally sound infrastructure play in a generous sector. But this quarter was not a stumble; it was a miss. Promised 30–35% growth, delivered 12.4%. Promised 50% profit expansion, saw profit fall 17%. The order book is real, the government receivables issue is real, and the margin recovery is an aspiration waiting for proof. The stock is repriced (₹303.85, down 70% from ATH), unloved (FII 0.44%), and waiting. The question for the next quarter is execution: can EMS deliver 30–35% QoQ growth, or is the order book visibility a mirage if receivables and project delays persist? Rating: Hold. The number to track from here is Q3 QoQ revenue growth. Miss it, and re-rate lower. Hit it, and the stock re-rates as a credible water/sewage infrastructure play with 2+ years of visible work. Receivables clearance and margin recovery are the supporting watch points.
Order book strength masks Q2 guidance miss and PAT decline
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Q2 FY27 missed 30-35% revenue target badly (delivered 12.4%). PAT -16.8% vs management's claim of 50% growth.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
EMS has a commanding order book (Rs. 3,152 Cr) and operates in a structurally sound sector (15 lakh crore water/sewage opportunity). But Q2 badly missed guidance (+12.4% revenue vs 30-35% target), PAT fell 16.8% YoY, and Rs. 450+ Cr in government receivables clogs cash. Management confidence on margin recovery to 25% is unproven. Hold pending Q3 delivery—if 30-35% QoQ growth holds, re-rate; if it misses again, downgrade.
₹193.9 Cr
Revenue · +12.4% YoY₹23.4 Cr
Reported PAT · −16.8% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
30% increase in operating income, 50% EBITDA/PAT growth in Q2
OVERSTATEDConsolidated Q2 FY27 revenue +12.4% YoY, PAT -16.8% YoY — massive underperformance vs claim
Q2 guidance was 30-35% YoY growth
MISSQ2 FY27 delivered 12.4% YoY revenue growth — 60% miss vs target
Order book Rs. 3,152 Cr added Rs. 900 Cr this quarter
METSupported by detail: Rs. 2,619 Cr CAPEX, Rs. 533 Cr O&M work. Aligns with CEO commentary
Receivables issue in Uttarakhand being resolved; fund flow normalizing
PartialStill carrying Rs. 450+ Cr trade receivables; government payment portal only recently corrected. High overhang
Can execute 40% of order book per year at typical 2-2.5yr project cycles
OVERSTATEDIf valid, Rs. 3,152 Cr ÷ 2.5 yrs = Rs. 1,261 Cr per year. At 40% execution = Rs. 504 Cr. Near Q2 revenue of 193.9 Cr
Earnings quality
What changed since the last call
Q2 guidance revised down from 30-35% to actual 12.4%
DowngradeFY27 Q2 target was 30-35% YoY revenue growth. Delivered 12.4%. 60% miss primarily due to Uttarakhand government receivables delays and monsoon-delayed work execution.
Q3 guidance cut from >50% to 30-35% QoQ
DowngradePrior call: Q3/Q4 expected >50% QoQ growth. Now management guidance: 30-35% QoQ. Reduction reflects realistic project execution timelines, not over-aspiration.
Order book upgraded Rs. 900 Cr to Rs. 3,152 Cr total
UpgradeNew tender wins from Jal boards (Delhi, PHED Rajasthan, UP Jal Nigam). Order book now 1.5x annual revenue vs 0.8x prior, strengthening visibility.
Receivables forecast: normalization by Q4 FY27
NeutralUttarakhand payment delays (Rs. 450+ Cr) attributed to government portal change (now resolved). Management expects funds inflow to accelerate, but still pending.
The Q&A
Analysts pressed hard on receivables (Uttarakhand payment delays, age of Rs. 450 Cr outstanding), order book execution (how much per year, what risks), and margin recovery (realistic EBITDA targets). Management held firm on execution capability but acknowledged external delays; did not concede Q2 miss was internal.
Receivables management — Ishita Lodha, Swan Investments
AnsweredUttarakhand receivables split across states; Amrit/Namami Ganga projects have no issue. Central government changed payment portal (took 4-6 months to normalize). Now resolved; expect fund inflow to accelerate.
Order book execution — Ishita Lodha, Swan Investments
AnsweredRs. 900 Cr received LOA this quarter. Rs. 1,600 Cr already under execution. Typical project lead time: 1.5-2.5 years from LOA to full execution. At 40% per year execution, can achieve Rs. 1,200+ Cr annual revenue.
Revenue per order book — Rahul Kumar, Individual Investor
PartialIf Rs. 3,000 Cr order book, 40% execution = Rs. 1,200 Cr. But Rs. 900 Cr received this quarter, so revised base smaller. Typical assumption: 40% per year of outstanding order book, with project cycles 2-2.5 years.
Geographic expansion — Rahul Kumar, Individual Investor
AnsweredCurrently pan-India operational. No foundation in any new state. Bidding opportunistically in Karnataka and wherever margins are strong. Focus on water supply and sewage networks where margin visibility exists.
H1 FY27 revenue decline — Shreya Kumari, Individual Investor
DodgedFY25-26 Q2 was bad due to Uttarakhand heavy rainfall; we couldn't execute. Prior year basis is weak. Q1 FY27-26 itself was lower. Comparing Q2 FY27 to Q2 FY25-26: around 30% improvement standalone. Sequential comparison stronger.
Project conversion timeline — Disha Shah, Individual Investor
AnsweredGovernment tender → L1 → ~2 months LOA formalities. Then 3-4 months engineering; work starts. Typically 6-8 months to first revenue recognition. 90% revenue in 2 years; 10% in 3 years for O&M holdback. Full O&M revenue starts 1 year post-defect liability.
EBITDA margin target — Disha Shah, Individual Investor
PartialPast EBITDA 28%-29%. PAT margins >20%. This quarter 22.26% EBITDA, 14.25% PAT. Expect close to 25% by FY27 end. Establishment costs fixed; machinery fixed. As revenue scales, margins improve. Currently ~2%-3%-4% profit margin project-to-project.
Government major project pipeline — Disha Shah, Individual Investor
AnsweredBidding aggressively; targeting Rs. 3,500 Cr new order book by Dec 2026. Expecting another 5,600 Cr order book increase. Already Rs. 900 Cr added in Q2. Target Rs. 3,000 Cr total order book by year-end.
Q2 vs prior guidance discrepancy — Dhruv Hingorani, Individual Investor
PartialUttarakhand receivables delayed project execution. Monsoon weather impact unavoidable. Prior year comparison weak (Q2 FY26 was bad quarter). Standalone performance better. Sequential growth intact; expect 30-35% QoQ Q3-Q4.
Margin recovery mechanism — Dhruv Hingorani, Individual Investor
DodgedEMS standalone profit increased 30% YoY. Operating income +28%. Consolidated reflects adjustments and subsidiary performance. Standalone is better indicator for core EMS performance.
Q3-Q4 confidence level — Dhruv Hingorani, Individual Investor
PartialIf Q1-Q2 show 30% jump and 50% profit growth, same pace can be maintained Q2-Q3 and Q3-Q4. Civil engineering: work completed = revenue. No day-to-day variance. Manpower fixed; machinery fixed. Operating leverage inherent.
Guidance
FY27 target Rs. 900-950 Cr (50% YoY growth) maintained implicitly
MediumNo explicit new FY27 target stated. Implied by Q3 30-35% QoQ + Q4 30-35% QoQ guidance, which would yield ~980+ Cr (upgraded from prior 900-950 range, but not formally stated).
Q3 FY27: 30-35% QoQ growth vs Q2 (prior >50% guide revised down)
MediumPrior guidance >50% QoQ for Q3/Q4. Now 30-35% more realistic given project cycles and execution timelines. Order book sufficient; execution risk remains.
Q4 FY27: 30-35% QoQ growth vs Q3
MediumAssumes Rs. 900 Cr new orders execute normally; no major receivables holdups. Dependent on government payment flow and project timelines.
EBITDA margin: 25%+ by FY27 end (vs current 18.5%)
MediumHistorical EBITDA 28-29%; PAT margins >20%. Recovery depends on cost control and revenue scaling. Currently 22.26% reported; gap of 2-3% to guidance.
PAT margin: 25% target by year-end (vs current 11.9%)
LowMajor uplift required. Current PAT margin compressed; PAT -16.8% YoY despite revenue growth. Suggests cost or non-operating headwinds not yet resolved.
No capex planned; all projects government-funded
HighEPC delivery model; government provides machinery and capital. EMS incurs engineering, labor costs only. Sustainable model requiring no balance-sheet capex.
Risks the call surfaced
Government receivables
HighRs. 450+ Cr trade receivables outstanding (primarily Uttarakhand). Government payment delays of 6+ months impair cash conversion and constrain operations.
Project execution risk
MediumOrder book visibility of Rs. 3,152 Cr assumes 40% annual conversion and 2-2.5 year project cycles. Weather delays (monsoon), government approval delays, and site conditions can compress margins.
Margin compression
MediumPAT margin 11.9% (vs historical 20%+). EBITDA margin 18.5% (vs target 25%+). Labor and material cost inflation, coupled with government project pricing pressure, could prevent recovery.
Guidance credibility
MediumQ2 FY27 missed 30-35% revenue target badly (delivered 12.4% YoY). PAT fell 16.8% YoY despite management claiming 50% growth. Investor confidence in forward guidance (30-35% QoQ Q3-Q4) is impaired.
Subsidiary performance
LowCEO reported standalone revenue 160.89 Cr and PAT 22.92 Cr, but consolidated results show 193.9 Cr revenue and 23.4 Cr PAT. Subsidiary contribution and loss drivers unclear.
Management
Score 7/10. Detailed on order book breakdown (state-wise, segment-wise) and project execution timelines. Transparent on receivables challenges and monsoon impact. Avoided acknowledging Q2 miss directly; deflected to past quarter difficulties. 20-year track record of 20% revenue CAGR. Q2 FY27 missed 30-35% guided target by 60%. PAT fell 16.8% YoY despite growth claims. Track record mixed; near-term credibility dented.
1 · Q3 FY27
30-35% QoQ revenue growth execution; Rs. 900 Cr new order book work starts
2 · Q4 FY27
Margin recovery to 25%+ EBITDA target; Uttarakhand receivables cleared
3 · FY28 Q1
Full-year visibility: Rs. 3,152 Cr order book momentum into next fiscal
Hold pending Q3 delivery—if 30-35% QoQ growth holds, re-rate; if it misses again, downgrade.
EMS Q2 FY27: PAT falls 16.7% YoY to ₹23.4 Cr, margins compress despite revenue growth
PAT -16.7% YoY · revenue +11.8% · margins compressing
₹193.9 Cr
+11.8% YoY
₹23.43 Cr
-16.7% YoY
11.92%
-3.9pp YoY
₹4.22
EMS Ltd's consolidated revenue for Q2 FY27 (quarter ended September 30, 2026) came in at ₹193.90 Cr, up 11.8% year-on-year and 23.3% sequentially, while consolidated PAT fell 16.7% YoY to ₹23.43 Cr even as it rose 51.2% QoQ. Standalone PAT was ₹22.93 Cr (basic EPS ₹4.13); consolidated basic EPS was ₹4.22, down from ₹5.08 a year ago. No verified analyst consensus for this stock specifically could be located, so the print cannot be benchmarked against street expectations here.
Q2 FY-2027 vs prior quarters
The YoY softness sits squarely in margins: consolidated NPM compressed to 11.9% from 15.8% a year ago, and OPM (EBITDA/revenue) to 18.6% from 21.4%, driven by a higher cost-of-sales and inventory-movement load relative to revenue plus a step-up in finance costs (₹4.93 Cr vs ₹2.65 Cr YoY). Sequentially both margins recovered sharply off Q1 FY27's trough (NPM 9.7%, OPM 16.6%), but the business has not regained its September-2025 profitability level.
The stock went into the print at ₹317.6, down 2.6% over the past month of trading.
FY27 full-year revenue target Rs. 900-950 Cr (50% YoY growth); expects Q2 +30-35%, Q3/Q4 >50% QoQ growth; EBITDA/PAT margins to recover to 2024-25 levels by year-end; no capex planned.
— This quarter: missed
This also reads as a miss against management's own guidance: the prior concall (August 2026) called for Q2 revenue growth of 30-35% YoY and a margin recovery to FY24-25 levels by year-end; actual YoY revenue growth of 11.8% is roughly a third of that target, and H1 FY27 revenue of ₹351.1 Cr trails H1 FY26's ₹412.4 Cr — making the stated FY27 target of ₹900-950 Cr (50% YoY) look increasingly stretched without an outsized H2. Notably, the company's own press release frames the quarter entirely in sequential terms ("EBITDA +37.5%", "PAT +51.2%" QoQ, attributed to "a surge in operating income" and resilient execution "amid strong rainy season"), without referencing the YoY profit decline or the shortfall against its own revenue guidance.
W1
Whether Q3/Q4 FY27 deliver the >50% QoQ growth management guided, needed to reach the FY27 revenue target of ₹900-950 Cr off a H1 base of ₹351.1 Cr
W2
Margin recovery toward FY24-25 levels (management's stated target) — OPM 18.6%/NPM 11.9% this quarter still trail the year-ago 21.4%/15.8%
W3
Conversion of the ₹3,152.78 Cr order book, including this quarter's ₹1,000+ Cr of fresh L1/LOA wins, into executed revenue
No exceptional items in current or year-ago quarter; figures cross-validated exactly against the company's own press-release QoQ tables. Consolidated PAT excludes JVs EMS Himal Hydro/EMS Singh (immaterial, no financials provided) and includes one subsidiary (Mirzapur Ghazipur STPS) not reviewed by the statutory auditor (small loss, no material impact).